Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases

Table 2 Summarized patient's and treatment data

Patient	Age/Sex	Untreated tumor growth	Initial procedure	Neodjuvant treatment for primary	Definite procedure	Ajuvant radiation to primary	Local and recurrence treatment	Metastasis and treatment	Status
1	30/F	3 months	incisional biopsy	etoposide, vincristine, adriamycin, ifosfamide	R0 resection	68 Gy	-	-	alive, NED
2	40/M	2 years	fine needle biopsy		R0 resection	60 Gy	-	right lower leg: R0 resection + radiation 60 Gy lung: R2 resection of 21 metastases brain: radiation 2 × 30Gy	DOD
3	21/M	3 years	incisional biopsy		R0 resection	60 Gy	+/adriamycin, ifosfamide	lung: adriamycin, ifosfamide brain: radiation 30 Gy liver: -	DOD
4	26/F	70 years	incisional biopsy		R0 resection	no	-	-	alive, NED
5	30/M	20 years	incisional biopsy	ILP: Melphalan + TNF-alpha	R0 resection	60 Gy	-	-	alive, NED
6	19/F	3 years	R1 resection		R0 resection	no	-	-	alive, NED
7	30/M	2 years	incisional biopsy		R0 resection	65 Gy	-	-	alive, NED
8	48/M	n/a	R1 resection		R1 resection	no	+/R0 resection	lung: epirubicin, ifosfamide brain: R1 resection liver: 5-FU, cisplatin	DOD
9	24/M	6 months	R1 resection		R0 resection	66 Gy	-	no	alive, NED
10	49/M	6 months	R1 resection		R0 resection	66 Gy	-	no	alive, NED
11	34/F	1 month	incisional biopsy		R0 resection	70,4 Gy	-	no	alive, NED

(F: female, M: male, R0-resection: complete resection with free margins, R1-resection: resection with microscopically positive margins, R2-resection: tumor masses remaining in situ, ILP: isolated limb perfusion, NED: no evidence of disease, DOD: died of disease)

ISSN: 1477-7819